International Journal of Immunotherapy and Cancer Research Submit Manuscript
    mendeley

    Immunogenicity in CAR T cell immunotherapy

    DOI Logo 10.17352/2455-8591.000038

    Published On: October 04, 2023 | Pages: 013 - 016

    Author(s): Emily Yu*

    ORCID Logo  0009-0008-8070-7781

    Currently, the most accessible forms of cancer treatment include surgery, chemotherapy, and radiation. However, these forms of treatment may damage or destroy healthy tissue as well as cancerous cells, resulting in side effects such as fatigue, hair loss, diarrhea, etc. Immunotherapy, an alternative form of cancer treatment, is a growing treatment method of interest t ... CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat
    Abstract View Full Article View
    mendeley

    The potential of mRNA vaccine in HCC treatment

    DOI Logo 10.17352/2455-8591.000037

    Published On: July 11, 2023 | Pages: 008 - 012

    Author(s): Rui Han*
    Neoantigen mRNA vaccines are a potential form of immunotherapy for Hepatocellular Carcinoma (HCC). These neoantigens can be targeted with personalized mRNA vaccines, which are designed to stimulate the patient’s immune system to recognize and destroy cancer cells. Neoantigen mRNA vaccines are developed using RNA sequences that are synthesized based on the genetic muta ... CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat
    Abstract View Full Article View
    mendeley

    Current understanding of the cardiotoxicity-related treatment of immune checkpoint inhibitors in breast cancer

    DOI Logo 10.17352/2455-8591.000036

    Published On: May 03, 2023 | Pages: 001 - 007

    Author(s): Jiajing Dai*

    ORCID Logo  0000-0003-1385-6820

    Immune Checkpoint Inhibitors (ICIs) as the most important and widely used currently, have changed the traditional approach to cancer treatment and significantly improved the prognosis of most patients with advanced malignancies. Breast cancer is the most dangerous threatening tumor to women’s health and life globally, ICIs have shed light on the treatment for refracto ... CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat
    Abstract View Full Article View

     

    Indexing/Archiving